Search Results for "Top 10 Neuroscience Projects To Watch 2013 14"

22:12 EST 2nd March 2015 | BioPortfolio

Matching Channels

Mesenchymal Epithelial Transition factor c MET

The c-MET signalling pathway consists of the mesenchymal epithelial transition factor (c-MET) transmembrane tyrosine kinase receptor and its ligand hepatocyte growth factor (HGF) or scatter factor (SF...

AstraZeneca

AstraZeneca is ranked 6th in the world, based on a pharmaceutical annual sales, which were valued at $32,800 million in 2009.  it is a global company, working in more than 100 countries, and em...

Staphylococcal aureus infections

Staphylococcal aureus infections represent an enormous burden to public health systems. Traditionally restricted to the hospital setting as nosocomial infections, highly virulent strains have recently...

Merck and Co

Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the ...

Lilly

Eli Lilly and Company was founded in 1876, and is now the 9th largest pharmaceutical company based an annual sales which were just under $20bn in 2009. Orginally from the USA, Lilly now operates in ...

Matching News

Where will big neuroscience take us?

(The Kavli Foundation) The US, Europe and Asia have launched big brain research projects. What impact will they have? Scientists integral to three projects share their insights ahead of a special sess...

Cynapsus’ APL-130277 one of “Top Ten Neurology Projects to Watch”

Cynapsus Therapeutics’ (OTCQX:CYNAF; TSX-V:CTH) APL-130277 drug candidate for Parkinson’s disease has been recognized as one of the “Top Ten Neurology Projects to Watch” by a joint sel...

Reversing Blindness and Eliminating Deafness

New grants for five research projects awarded by the Bertarelli Program in Translational Neuroscience and Neuroengineering The Bertarelli Program in Translational Neuroscience and Neuroengineering, a ...

Neuroscience Treatments To Watch

Breakthroughs in genetics and sheer stubbornness on the part of drug developers could soon lead to new drugs for intractable brain diseases, including:

Stocks To Watch If You're Betting on the Brain

Want to invest in neo-neuroscience? Here's our red-yellow-green take on eight stocks attracting investor attention.

Stocks To Watch If You’re Betting on the Brain

Want to invest in neo-neuroscience? Here's our red-yellow-green take on eight stocks attracting investor attention.

J&J, U of Toronto in neuroscience deal

The Janssen Biotech Inc. subsidiary of Johnson & Johnson (NYSE:JNJ) partnered with the University of Toronto's Center for Collaborative Drug Research (CCDR) to develop therapies to treat mood disorder...

The Apple Watch and Health

Apple recently unveiled its smart watch.  The watch not only is a mini-computer, but it can help improve your health. Pharmafile reports: The watch comes with an app that promises to calculate all ki...

Matching PubMed Articles

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement